HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
ALGS holding history
Aligos Therapeutics, Inc.
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding ALGS, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
ALGS overviewAll 13F holders of ALGSFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 76,247 | $439.95K | 0.05% | 00.0% | Unchanged |
| Q1 2026 | 76,247 | $566.52K | 0.03% | 00.0% | Unchanged |
| Q4 2025 | 76,247 | $710.62K | 0.02% | 00.0% | Unchanged |
| Q3 2025 | 76,247 | $747.22K | 0.02% | 00.0% | Unchanged |
| Q2 2025 | 76,247 | $549.74K | 0.02% | 00.0% | Unchanged |
| Q1 2025 | 76,247 | $629.04K | 0.02% | 00.0% | Unchanged |
| Q4 2024 | 76,247 | $3.04M | 0.11% | 00.0% | Unchanged |
| Q3 2024 | 76,247 | $660.3K | 0.01% | −3,045,442−97.6% | Reduced |
| Q2 2024 | 3,121,689 | $1.09M | 0.03% | +1,215,498+63.8% | Added |
| Q1 2024 | 1,906,191 | $1.87M | 0.04% | 00.0% | Unchanged |
| Q4 2023 | 1,906,191 | $1.27M | 0.03% | −403,573−17.5% | Reduced |
| Q3 2023 | 2,309,764 | $1.73M | 0.04% | 00.0% | Unchanged |
| Q2 2023 | 2,309,764 | $2.24M | 0.05% | 00.0% | Unchanged |
| Q1 2023 | 2,309,764 | $2.02M | 0.04% | 00.0% | Unchanged |
| Q4 2022 | 2,309,764 | $2.2M | 0.05% | −55,300−2.3% | Reduced |
| Q3 2022 | 2,365,064 | $2.6M | 0.07% | 00.0% | Unchanged |
| Q2 2022 | 2,365,064 | $2.86M | 0.06% | 00.0% | Unchanged |
| Q1 2022 | 2,365,064 | $5.09M | 0.11% | 00.0% | Unchanged |
| Q4 2021 | 2,365,064 | $28.07M | 0.43% | 00.0% | Unchanged |
| Q3 2021 | 2,365,064 | $36.68M | 0.48% | +200,000+9.2% | Added |
| Q2 2021 | 2,165,064 | $44.14M | 0.45% | 00.0% | Unchanged |
| Q1 2021 | 2,165,064 | $49.23M | 0.49% | +2,165,064 | New |